{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:18:05Z","timestamp":1787807885329,"version":"build-2784847793"},"reference-count":195,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM142944"],"award-info":[{"award-number":["R35GM142944"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jconrel.2026.115157","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:07:22Z","timestamp":1783120042000},"page":"115157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["New approach methodologies (NAMs) for preclinical and translational evaluation of mRNA\u2013lipid nanoparticle (LNP) therapeutics"],"prefix":"10.1016","volume":"397","author":[{"given":"Jiawei","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Kabanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Polacheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanguang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115157_bb0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115157_bb0010","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","article-title":"mRNA-based cancer therapeutics","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115157_bb0015","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.molmed.2021.03.003","article-title":"Lipid nanoparticle-mediated delivery of mRNA therapeutics and vaccines","volume":"27","author":"Swingle","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115157_bb0020","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.115157_bb0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2020.06.017","article-title":"Lipid-based nanoparticle technologies for liver targeting","volume":"154\u2013155","author":"B\u00f6ttger","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115157_bb0030","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s12276-023-00999-x","article-title":"Knife\u2019s edge: balancing immunogenicity and reactogenicity in mRNA vaccines","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115157_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126420","article-title":"Lipid nanoparticle-based mRNA therapeutics for infectious diseases","volume":"687","author":"Kumar","year":"2026","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115157_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.128059","article-title":"Evolution and trends in non-viral mRNA Cancer vaccines: a scoping review from 2015 to 2025","volume":"71","author":"Nowzari","year":"2026","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2026.115157_bb0045","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1126\/science.ads8473","article-title":"In vivo CAR T cell generation to treat cancer and autoimmune disease","volume":"388","author":"Hunter","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115157_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/biom13101497","article-title":"Enabling mRNA therapeutics: current landscape and challenges in manufacturing","volume":"13","author":"Youssef","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2026.115157_bb0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1039\/D5PM00159E","article-title":"mRNA therapeutics beyond vaccines: dosing precision challenges and clinical translation framework","volume":"3","author":"Niazi","year":"2026","journal-title":"RSC Pharm."},{"key":"10.1016\/j.jconrel.2026.115157_bb0060","first-page":"253","article-title":"In vitro and in vivo evaluation of an mRNA therapeutic for the treatment of patients with cystic fibrosis","author":"Barbier","year":"2018","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0065","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcf.2023.04.008","article-title":"Inhaled mRNA therapy for treatment of cystic fibrosis: interim results of a randomized, double-blind, placebo-controlled phase 1\/2 clinical study","volume":"22","author":"Rowe","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jconrel.2026.115157_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat9143","article-title":"Durable anticancer immunity from intratumoral administration of IL-23, IL-36\u03b3, and OX40L mRNAs","volume":"11","author":"Hewitt","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115157_bb0075","article-title":"PD-1 blockade and OX40 triggering synergistically protects against tumor growth in a murine model of ovarian cancer","volume":"9","author":"Guo","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jconrel.2026.115157_bb0080","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf115","article-title":"First-in-human phase I\/II, open-label study of mRNA-2416 alone or combined with durvalumab in patients with advanced solid tumors and ovarian cancer","volume":"30","author":"Sullivan","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.jconrel.2026.115157_bb0085","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115157_bb0090","series-title":"Roadmap to Reducing Animal Testing in Preclinical Safety Studies","author":"Food, D. Administration","year":"2025"},{"key":"10.1016\/j.jconrel.2026.115157_bb0095","article-title":"Why animal model studies are lost in translation","volume":"2","author":"Frangogiannis","year":"2022","journal-title":"J. Cardiovasc. Aging"},{"key":"10.1016\/j.jconrel.2026.115157_bb0100","first-page":"E255","article-title":"Ethical considerations regarding animal experimentation","volume":"63","author":"Kiani","year":"2022","journal-title":"J. Prev. Med. Hyg."},{"key":"10.1016\/j.jconrel.2026.115157_bb0105","doi-asserted-by":"crossref","DOI":"10.1093\/toxres\/tfae044","article-title":"New approach methodologies (NAMs): identifying and overcoming hurdles to accelerated adoption","volume":"13","author":"Sewell","year":"2024","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.jconrel.2026.115157_bb0110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/aor.14503","article-title":"FDA modernization act 2.0 allows for alternatives to animal testing","volume":"47","author":"Han","year":"2023","journal-title":"Artif. Organs"},{"key":"10.1016\/j.jconrel.2026.115157_bb0115","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s43441-024-00686-7","article-title":"Insights into early interactions on innovative developments with European regulators","volume":"58","author":"Uster","year":"2024","journal-title":"Ther. Innov. Regul. Sci."},{"key":"10.1016\/j.jconrel.2026.115157_bb0120","series-title":"FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs","author":"F.a.D. Administration","year":"2025"},{"key":"10.1016\/j.jconrel.2026.115157_bb0125","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/cpt.70046","article-title":"New approach methodologies: what clinical pharmacologists should prepare for","volume":"118","author":"Cao","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.115157_bb0130","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/cpt.70049","article-title":"Promise of quantitative proteomics in the qualification of new approach methodologies","volume":"118","author":"Prasad","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.115157_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s42826-024-00195-6","article-title":"A review of animal models utilized in preclinical studies of approved gene therapy products: trends and insights","volume":"40","author":"Soufizadeh","year":"2024","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.jconrel.2026.115157_bb0140","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1158\/2326-6066.CIR-24-1046","article-title":"The problem with syngeneic mouse tumor models","volume":"13","author":"Lonberg","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2026.115157_bb0145","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1038\/s41467-023-39938-9","article-title":"mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115157_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012090","article-title":"mRNA-encoded mutant HPV16\/18 vaccines promote specific T-cell responses and synergize with anti-PD-1 checkpoint blockade in mediating therapeutic tumor regression in mice","volume":"13","author":"Zhang","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115157_bb0155","article-title":"Local administration of mRNA encoding cytokine cocktail confers potent anti-tumor immunity","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0160","article-title":"Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115157_bb0165","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115157_bb0170","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41416-019-0495-5","article-title":"The role of mouse tumour models in the discovery and development of anticancer drugs","volume":"121","author":"Ireson","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.115157_bb0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","article-title":"Preclinical mouse cancer models: a maze of opportunities and challenges","volume":"163","author":"Day","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115157_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102860","article-title":"mRNA-lipid nanoparticle (LNP) delivery of humanized EpCAM-CD3 bispecific antibody significantly blocks colorectal cancer tumor growth","volume":"15","author":"Golubovskaya","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115157_bb0185","article-title":"Lipid nanoparticle delivery system for mRNA encoding B7H3-redirected bispecific antibody displays potent antitumor effects on malignant tumors","volume":"10","author":"Huang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jconrel.2026.115157_bb0190","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jconrel.2023.04.005","article-title":"High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo","volume":"357","author":"Huayamares","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115157_bb0195","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","article-title":"Patient-derived xenograft models in cancer therapy: technologies and applications","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115157_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116603","article-title":"Intratumoural delivery of TRAIL mRNA induces colon cancer cell apoptosis","volume":"174","author":"Gu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2026.115157_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114383","article-title":"mRNA nanomedicine reprograms the cell cycle to increase the effectiveness of targeted therapy for HER2-low breast cancers","volume":"388","author":"Wang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115157_bb0210","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/s41598-025-31128-5","article-title":"Targeting fibroblast activation protein in solid tumors via LNP-mediated CAR-mRNA delivery promotes durable regression in murine models","volume":"16","author":"Meng","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115157_bb0215","doi-asserted-by":"crossref","first-page":"12695","DOI":"10.1021\/acsnano.2c04420","article-title":"Lipid nanoparticle delivery of Fas plasmid restores Fas expression to suppress melanoma growth in Vivo","volume":"16","author":"Al Subeh","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115157_bb0220","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","article-title":"Humanized mouse models for immuno-oncology research","volume":"20","author":"Chuprin","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0225","first-page":"4568","article-title":"Humanized mouse model: a review on preclinical applications for cancer immunotherapy","volume":"10","author":"Yin","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115157_bb0230","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011415","article-title":"Lipid nanoparticle-delivered IFN\u03b12 activates Cxcl9 to increase T cell tumor recruitment to suppress lung metastasis","volume":"13","author":"Fick","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115157_bb0235","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adn0622","article-title":"mRNA-LNP prime boost evolves precursors toward VRC01-like broadly neutralizing antibodies in preclinical humanized mouse models","volume":"9","author":"Wang","year":"2024","journal-title":"Sci. Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2026.115157_bb0240","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1093\/infdis\/jit319","article-title":"Overcoming current limitations in humanized mouse research","volume":"208","author":"Brehm","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2026.115157_bb0245","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41565-021-01030-y","article-title":"Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles","volume":"17","author":"Hatit","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.15252\/emmm.201606857","article-title":"Genetically engineered mouse models in oncology research and cancer medicine","volume":"9","author":"Kersten","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115157_bb0255","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.ymthe.2025.01.010","article-title":"Characterization of a novel conditional knockout mouse model to assess efficacy of mRNA therapy in the context of severe OTC deficiency","volume":"33","author":"Zhou","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115157_bb0260","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.omtm.2023.02.007","article-title":"Lipid nanoparticle-encapsulated mRNA therapy corrects serum total bilirubin level in Crigler-Najjar syndrome mouse model","volume":"29","author":"Greig","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2026.115157_bb0265","doi-asserted-by":"crossref","first-page":"E9944","DOI":"10.1073\/pnas.1811276115","article-title":"High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing","volume":"115","author":"Sago","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115157_bb0270","doi-asserted-by":"crossref","first-page":"10025","DOI":"10.1021\/acs.nanolett.2c03741","article-title":"The extent to which lipid nanoparticles require apolipoprotein E and low-density lipoprotein receptor for delivery changes with Ionizable lipid structure","volume":"22","author":"Paunovska","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115157_bb0275","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1200\/JCO.2010.30.8304","article-title":"How genetically engineered mouse tumor models provide insights into human cancers","volume":"29","author":"Politi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202211420","article-title":"Optimizing lipid nanoparticles for delivery in primates","volume":"35","author":"Lam","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115157_bb0285","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2021.05.021","article-title":"Impact of lipid nanoparticle size on mRNA vaccine immunogenicity","volume":"335","author":"Hassett","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115157_bb0290","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.175401","article-title":"Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans","volume":"9","author":"Hellgren","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2026.115157_bb0295","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41577-018-0005-7","article-title":"Nonhuman primate models of human viral infections","volume":"18","author":"Estes","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0300","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ilar\/ilx033","article-title":"Nonhuman primates and translational research: progress, opportunities, and challenges","volume":"58","author":"Harding","year":"2017","journal-title":"ILAR J."},{"key":"10.1016\/j.jconrel.2026.115157_bb0305","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jhep.2021.08.011","article-title":"Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model","volume":"75","author":"Yang","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0310","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adv2293","article-title":"Metabolism-programming mRNA-lipid nanoparticles remodel the immune microenvironment to improve immunotherapy against MAFLD","volume":"17","author":"Yu","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115157_bb0315","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1016\/j.ymthe.2025.09.011","article-title":"Immunology of RNA-based vaccines: the critical interplay between inflammation and expression","volume":"33","author":"Tregoning","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115157_bb0320","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems vaccinology of the BNT162b2 mRNA vaccine in humans","volume":"596","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115157_bb0325","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults","volume":"383","author":"Anderson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115157_bb0330","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115157_bb0335","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0340","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/nri3587","article-title":"Innate immunity: making mice more human the TLR8 way","volume":"14","author":"Kugelberg","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0345","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cell.2019.11.001","article-title":"TLR8 is a sensor of RNase T2 degradation products","volume":"179","author":"Greulich","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115157_bb0350","doi-asserted-by":"crossref","first-page":"11804","DOI":"10.1021\/acs.analchem.6b03437","article-title":"Analysis of pre-existing IgG and IgM antibodies against polyethylene glycol (PEG) in the general population","volume":"88","author":"Yang","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2026.115157_bb0355","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115157_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115005","article-title":"Formation of fenestrae in murine liver sinusoids depends on plasmalemma vesicle-associated protein and is required for lipoprotein passage","volume":"9","author":"Herrnberger","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jconrel.2026.115157_bb0365","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-020-00411-3","article-title":"Role of liver sinusoidal endothelial cells in liver diseases","volume":"18","author":"Gracia-Sancho","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0370","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/ar.24560","article-title":"Hepatic sinusoids versus central veins: structures, markers, angiocrines, and roles in liver regeneration and homeostasis","volume":"304","author":"Mak","year":"2021","journal-title":"Anat. Rec."},{"key":"10.1016\/j.jconrel.2026.115157_bb0375","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115157_bb0380","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1001\/jama.2021.5374","article-title":"Reactogenicity following receipt of mRNA-based COVID-19 vaccines","volume":"325","author":"Chapin-Bardales","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.jconrel.2026.115157_bb0385","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12879-022-07284-8","article-title":"Effect of gender, age and vaccine on reactogenicity and incapacity to work after COVID-19 vaccination: a survey among health care workers","volume":"22","author":"Nachtigall","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jconrel.2026.115157_bb0390","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s44164-025-00096-5","article-title":"Pre-clinical evaluation of mRNA-lipid nanoparticles' potency and toxicity: current practices and future directions","volume":"4","author":"Muzard","year":"2025","journal-title":"In Vitro Model"},{"key":"10.1016\/j.jconrel.2026.115157_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313054","article-title":"Review of hTERT-immortalized cells: how to assess immortality and confirm identity","volume":"25","author":"Shitova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115157_bb0400","article-title":"Cell immortality: in vitro effective techniques to achieve and investigate its applications and challenges","volume":"14","author":"Chalak","year":"2024","journal-title":"Life (Basel)"},{"key":"10.1016\/j.jconrel.2026.115157_bb0405","article-title":"Development and characterization of an in vitro cell-based assay to predict potency of mRNA-LNP-based vaccines","volume":"11","author":"Patel","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2026.115157_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612716","article-title":"Practical use of immortalized cells in medicine: current advances and future perspectives","volume":"24","author":"Voloshin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115157_bb0415","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.711381","article-title":"From donor to the lab: a fascinating journey of primary cell lines","volume":"9","author":"Richter","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101470","article-title":"Serum factors create species-specific barriers to hepatic gene transfer by lipid nanoparticles in liver-humanized mice","volume":"33","author":"Stone","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2026.115157_bb0425","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8247935","article-title":"SERPINA1 mRNA as a treatment for Alpha-1 antitrypsin deficiency","volume":"2018","author":"Connolly","year":"2018","journal-title":"J. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2026.115157_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/nu15010040","article-title":"A comparison of primary human hepatocytes and hepatoma cell lines to model the effects of fatty acids, fructose and glucose on liver cell lipid accumulation","volume":"15","author":"Huggett","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jconrel.2026.115157_bb0435","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","article-title":"Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications","volume":"9","author":"Cerneckis","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115157_bb0440","doi-asserted-by":"crossref","first-page":"107","DOI":"10.15283\/ijsc24118","article-title":"Advanced animal replacement testing strategies using stem cell and organoids","volume":"18","author":"Lee","year":"2025","journal-title":"Int. J. Stem Cells"},{"key":"10.1016\/j.jconrel.2026.115157_bb0445","doi-asserted-by":"crossref","first-page":"23466","DOI":"10.1021\/acsnano.3c05341","article-title":"Fusogenic coiled-coil peptides enhance lipid nanoparticle-mediated mRNA delivery upon Intramyocardial administration","volume":"17","author":"Zeng","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115157_bb0450","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jconrel.2024.04.018","article-title":"Cardiac delivery of modified mRNA using lipid nanoparticles: cellular targets and biodistribution after intramyocardial administration","volume":"369","author":"Labonia","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115157_bb0455","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1093\/neuonc\/noaf162","article-title":"Lipid nanoparticle formulation for gene editing and RNA-based therapies for glioblastoma","volume":"27","author":"Zhang","year":"2025","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115157_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101427","article-title":"mRNA-LNP vaccine strategies: effects of adjuvants on non-parenchymal liver cells and tolerance","volume":"33","author":"Svensson","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2026.115157_bb0465","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41551-023-01131-0","article-title":"Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity","volume":"8","author":"Zhu","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115157_bb0470","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3389\/fbioe.2020.00911","article-title":"Impact of culture medium on cellular interactions in in vitro co-culture systems","volume":"8","author":"Vis","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0475","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/7651_2024_537","article-title":"Principles of indirect co-culture method using transwell","volume":"2939","author":"Rasouli","year":"2025","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0480","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1021\/acs.nanolett.3c03509","article-title":"Predictive high-throughput platform for dual screening of mRNA lipid nanoparticle blood-brain barrier transfection and crossing","volume":"24","author":"Han","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115157_bb0485","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj0006","article-title":"Dynamically covalent lipid nanoparticles mediate CRISPR-Cas9 genome editing against choroidal neovascularization in mice","volume":"11","author":"Cao","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115157_bb0490","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1021\/acsnano.1c10534","article-title":"Substrate stiffness-driven membrane tension modulates vesicular trafficking via caveolin-1","volume":"16","author":"Lachowski","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115157_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2022.102427","article-title":"Capturing the mechanics of clathrin-mediated endocytosis","volume":"75","author":"Smith","year":"2022","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0500","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1039\/C7LC01248A","article-title":"Use of porous membranes in tissue barrier and co-culture models","volume":"18","author":"Chung","year":"2018","journal-title":"Lab Chip"},{"key":"10.1016\/j.jconrel.2026.115157_bb0505","first-page":"910","article-title":"2D and 3D cell cultures - a comparison of different types of cancer cell cultures","volume":"14","author":"Kapa\u0142czy\u0144ska","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.jconrel.2026.115157_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122408","article-title":"A comprehensive review on 3D tissue models: biofabrication technologies and preclinical applications","volume":"304","author":"Xie","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115157_bb0515","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/adt.2014.573","article-title":"Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors","volume":"12","author":"Edmondson","year":"2014","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113756","article-title":"Lipid nanoparticles with prazole adjuvant to enhance the efficacy of mRNA cancer vaccines","volume":"383","author":"Kim","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115157_bb0525","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bjh.19988","article-title":"mRNA-laden lipid nanoparticle-enabled humanized CD19 CAR-T-cell engineering for the eradication of leukaemic cells","volume":"206","author":"Chen","year":"2025","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0530","series-title":"Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts)","article-title":"Lipid nanoparticle screening in 2D vs 3D cultures: Ovarian cancer cell lines exhibit different preference for optimal lipid formulation in monolayers vs spheroids [abstract]","author":"Taylor","year":"2025"},{"key":"10.1016\/j.jconrel.2026.115157_bb0535","doi-asserted-by":"crossref","DOI":"10.3390\/cells14100732","article-title":"Modeling tumor microenvironment complexity in vitro: spheroids as physiologically relevant tumor models and strategies for their analysis","volume":"14","author":"Shah","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.115157_bb0540","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-12556-9","article-title":"Development of tetraculture spheroids as a versatile 3D model for personalized breast cancer research","volume":"15","author":"Piwocka","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115157_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17071161","article-title":"Mimicking the complexity of solid tumors: how spheroids could advance cancer preclinical transformative approaches","volume":"17","author":"Mangani","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"2023","key":"10.1016\/j.jconrel.2026.115157_bb0550","article-title":"Organoids: the current status and biomedical applications","volume":"4","author":"Yang","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.jconrel.2026.115157_bb0555","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.tibtech.2025.02.009","article-title":"Brain organoids: building higher-order complexity and neural circuitry models","volume":"43","author":"Maisumu","year":"2025","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/cells11182803","article-title":"Cerebral organoids as an experimental platform for human neurogenomics","volume":"11","author":"Nowakowski","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.115157_bb0565","doi-asserted-by":"crossref","first-page":"36106","DOI":"10.1021\/acsnano.4c15013","article-title":"AI-validated brain targeted mRNA lipid nanoparticles with neuronal tropism","volume":"19","author":"Sela","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115157_bb0570","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1351734","article-title":"Brain organoid protocols and limitations","volume":"18","author":"Zhao","year":"2024","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jconrel.2026.115157_bb0575","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2025.02.010","article-title":"Vascular network-inspired diffusible scaffolds for engineering functional midbrain organoids","volume":"32","author":"Cai","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jconrel.2026.115157_bb0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002141","article-title":"Approaches to vascularizing human brain organoids","volume":"21","author":"Ye","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0585","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10456-024-09905-z","article-title":"Vascularized organoid-on-a-chip: design, imaging, and analysis","volume":"27","author":"Yu","year":"2024","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jconrel.2026.115157_bb0590","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41467-024-45710-4","article-title":"A microfluidic platform integrating functional vascularized organoids-on-chip","volume":"15","author":"Quintard","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115157_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118529","article-title":"Engineering next generation vascularized organoids","volume":"398","author":"Werschler","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jconrel.2026.115157_bb0600","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","article-title":"Human organs-on-chips for disease modelling, drug development and personalized medicine","volume":"23","author":"Ingber","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2026.115157_bb0605","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240289","article-title":"Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting","volume":"221","author":"Jeger-Madiot","year":"2024","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115157_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2026.116416","article-title":"In vitro recapitulation of intramuscular mRNA vaccination with naive and recall antigens using a human lymphoid follicle chip platform","volume":"29","author":"Zhai","year":"2026","journal-title":"iScience"},{"key":"10.1016\/j.jconrel.2026.115157_bb0615","first-page":"1","article-title":"A microphysiological system for screening lipid nanoparticle-mRNA complexes predicts in vivo heart transfection efficacy","author":"Neiman","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115157_bb0620","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1039\/D1LC00067E","article-title":"High-throughput organ-on-chip platform with integrated programmable fluid flow and real-time sensing for complex tissue models in drug development workflows","volume":"21","author":"Azizgolshani","year":"2021","journal-title":"Lab Chip"},{"key":"10.1016\/j.jconrel.2026.115157_bb0625","first-page":"E2293","article-title":"Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115157_bb0630","doi-asserted-by":"crossref","DOI":"10.1063\/5.0019766","article-title":"Organ-on-a-disc: A platform technology for the centrifugal generation and culture of microphysiological 3D cell constructs amenable for automation and parallelization","volume":"4","author":"Schneider","year":"2020","journal-title":"APL Bioeng."},{"key":"10.1016\/j.jconrel.2026.115157_bb0635","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350519","article-title":"Whole blood stimulation as a tool for studying the human immune system","volume":"54","author":"M\u00fcller","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0640","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ymgme.2022.10.001","article-title":"SARS-CoV-2 mRNA-based vaccines in the Aicardi Gouti\u00e8res syndrome","volume":"137","author":"Takanohashi","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jconrel.2026.115157_bb0645","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.ymthe.2024.12.019","article-title":"mRNA-LNPs induce immune activation and cytokine release in human whole blood assays across diverse health conditions","volume":"33","author":"Nguyen","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115157_bb0650","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1756-0500-6-120","article-title":"Comparison of whole blood and PBMC assays for T-cell functional analysis","volume":"6","author":"Deenadayalan","year":"2013","journal-title":"BMC. Res. Notes"},{"key":"10.1016\/j.jconrel.2026.115157_bb0655","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073595","article-title":"mRNA-LNP COVID-19 vaccine lipids induce complement activation and production of proinflammatory cytokines: mechanisms, effects of complement inhibitors, and relevance to adverse reactions","volume":"25","author":"Bakos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115157_bb0660","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16060771","article-title":"Optimizing mRNA-loaded lipid nanoparticles as a potential tool for protein-replacement therapy","volume":"16","author":"Gambaro","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115157_bb0665","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115157_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101136","article-title":"Novel methods to determine complement activation in human serum induced by the complex of dezamizumab and serum amyloid P","volume":"297","author":"Ma","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.115157_bb0675","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122870","article-title":"Dynamic physiological culture of ex vivo human tissue: a systematic review","volume":"13","author":"Hughes","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115157_bb0680","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s13346-024-01715-6","article-title":"Targeted lipid nanoparticles to prevent trans-placental passage in the ex vivo human placental cotyledon perfusion model","volume":"15","author":"van Kammen","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.115157_bb0685","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.13.7.7","article-title":"Lipid nanoparticle-mediated delivery of mRNA into the mouse and human retina and other ocular tissues","volume":"13","author":"Chambers","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0690","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1021\/acsnano.9b01774","article-title":"The skin you are in: design-of-experiments optimization of lipid nanoparticle self-amplifying RNA formulations in human skin explants","volume":"13","author":"Blakney","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115157_bb0695","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jtcvs.2025.10.021","article-title":"Safety risks of intratracheal lipid nanoparticle gene delivery to the lung and potential mitigation strategies","volume":"171","author":"Nagoya","year":"2026","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.jconrel.2026.115157_bb0700","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.12688\/f1000research.142014.1","article-title":"Ex vivo precision-cut liver slices model disease phenotype and monitor therapeutic response for liver monogenic diseases","volume":"12","author":"Perocheau","year":"2023","journal-title":"F1000Res"},{"key":"10.1016\/j.jconrel.2026.115157_bb0705","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2012.4","article-title":"Basic concepts in population modeling, simulation, and model-based drug development","volume":"1","author":"Mould","year":"2012","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0710","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2013.41","article-title":"Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development","volume":"2","author":"Jones","year":"2013","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0715","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/cpt.3641","article-title":"Model-informed drug development applications and opportunities in mRNA-LNP therapeutics","volume":"118","author":"Zhou","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.115157_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102175","article-title":"Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system","volume":"35","author":"Parhiz","year":"2024","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.jconrel.2026.115157_bb0725","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/074823379701300401","article-title":"Physiological parameter values for physiologically based pharmacokinetic models","volume":"13","author":"Brown","year":"1997","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.jconrel.2026.115157_bb0730","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11095-013-1127-z","article-title":"Dual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B disposition","volume":"31","author":"Kagan","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.115157_bb0735","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00003088-200645050-00006","article-title":"A novel strategy for physiologically based predictions of human pharmacokinetics","volume":"45","author":"Jones","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2026.115157_bb0740","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1016\/j.apsb.2024.06.011","article-title":"Modeling on in vivo disposition and cellular transportation of RNA lipid nanoparticles via quantum mechanics\/physiologically-based pharmacokinetic approaches","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115157_bb0745","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1208\/s12248-025-01155-1","article-title":"Physiologically based pharmacokinetic modeling and simulation in regulatory review: US FDA CBER experience and perspectives","volume":"27","author":"Tegenge","year":"2025","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2026.115157_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114468","article-title":"Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: opportunities and challenges","volume":"189","author":"Fairman","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0755","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.xphs.2018.10.037","article-title":"Physiologically based pharmacokinetic modeling of nanoparticles","volume":"108","author":"Yuan","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115157_bb0760","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/psp4.12426","article-title":"Quantitative systems pharmacology: an exemplar model-building workflow with applications in cardiovascular, metabolic, and oncology drug development","volume":"8","author":"Helmlinger","year":"2019","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0765","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10928-023-09871-x","article-title":"Assessing the performance of QSP models: biology as the driver for validation","volume":"51","author":"Singh","year":"2024","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.jconrel.2026.115157_bb0770","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/psp4.12225","article-title":"Logic modeling in quantitative systems pharmacology","volume":"6","author":"Traynard","year":"2017","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0775","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/psp4.70127","article-title":"QSP-copilot: an AI-augmented platform for accelerating quantitative systems pharmacology model development","volume":"14","author":"Saini","year":"2025","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0780","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/psp4.70041","article-title":"A multiscale quantitative systems pharmacology model for the development and optimization of mRNA vaccines","volume":"14","author":"Dasti","year":"2025","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0785","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/psp4.13270","article-title":"An integrated quantitative systems pharmacology virtual population approach for calibration with oncology efficacy endpoints","volume":"14","author":"Braniff","year":"2025","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0790","doi-asserted-by":"crossref","DOI":"10.3389\/fnano.2024.1330406","article-title":"Development of a minimal PBPK-QSP modeling platform for LNP-mRNA based therapeutics to study tissue disposition and protein expression dynamics","volume":"6","author":"Miyazawa","year":"2024","journal-title":"Front. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0795","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.2147\/DDDT.S121520","article-title":"Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013","volume":"10","author":"Suh","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2026.115157_bb0800","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/psp4.12301","article-title":"Quantitative systems pharmacology model of hUGT1A1-modRNA encoding for the UGT1A1 enzyme to treat Crigler-Najjar syndrome type 1","volume":"7","author":"Apgar","year":"2018","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0805","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41573-025-01308-z","article-title":"Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety","volume":"25","author":"Goldring","year":"2026","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115157_bb0810","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/psp4.13227","article-title":"Quantitative systems toxicology modeling in pharmaceutical research and development: an industry-wide survey and selected case study examples","volume":"13","author":"Beattie","year":"2024","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0815","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cotox.2020.06.003","article-title":"DILIsym: quantitative systems toxicology impacting drug development","volume":"23","author":"Watkins","year":"2020","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0820","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/psp4.12381","article-title":"Best practices to maximize the use and reuse of quantitative and systems pharmacology models: recommendations from the United Kingdom quantitative and systems pharmacology network","volume":"8","author":"Cucurull-Sanchez","year":"2019","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0825","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.arth.2023.08.045","article-title":"Demystifying statistics and machine learning in analysis of structured tabular data","volume":"38","author":"Khosravi","year":"2023","journal-title":"J. Arthroplast."},{"key":"10.1016\/j.jconrel.2026.115157_bb0830","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/computers12050091","article-title":"Understanding of machine learning with deep learning: architectures, workflow, applications and future directions","volume":"12","author":"Taye","year":"2023","journal-title":"Computers"},{"key":"10.1016\/j.jconrel.2026.115157_bb0835","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41746-024-01360-w","article-title":"Estimation of minimal data sets sizes for machine learning predictions in digital mental health interventions","volume":"7","author":"Zantvoort","year":"2024","journal-title":"NPJ Digit. Med."},{"key":"10.1016\/j.jconrel.2026.115157_bb0840","doi-asserted-by":"crossref","first-page":"99129","DOI":"10.1109\/ACCESS.2022.3207287","article-title":"A survey of ensemble learning: concepts, algorithms, applications, and prospects","volume":"10","author":"Mienye","year":"2022","journal-title":"IEEE Access"},{"key":"10.1016\/j.jconrel.2026.115157_bb0845","series-title":"Computer Science on-Line Conference","first-page":"15","article-title":"A review of evaluation metrics in machine learning algorithms","author":"Naidu","year":"2023"},{"key":"10.1016\/j.jconrel.2026.115157_bb0850","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1038\/s41467-024-50619-z","article-title":"AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery","volume":"15","author":"Xu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115157_bb0855","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41563-024-01867-3","article-title":"Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry","volume":"23","author":"Li","year":"2024","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115157_bb0860","article-title":"A novel machine learning framework-based rapid screening of ionizable lipids in LNPs for highly-efficient mRNA expression","author":"Duan","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115157_bb0865","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55072-6","article-title":"Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"issue":"27","key":"10.1016\/j.jconrel.2026.115157_bb0870","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202525076","article-title":"PRELIVE: a framework for predicting lipid nanoparticles in vivo efficacy and reducing reliance on animal testing","volume":"36","author":"Hanafy","year":"2026","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115157_bb0875","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/s41587-024-02490-y","article-title":"Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy","volume":"43","author":"Witten","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0880","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1021\/acsabm.5c01883","article-title":"Machine learning for the prediction of size and encapsulation efficiency of mRNA-loaded lipid nanoparticles following a Postencapsulation approach","volume":"9","author":"Duffr\u00e8ne","year":"2026","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2026.115157_bb0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.100996","article-title":"Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost\/Bayesian method and ensemble model approaches","volume":"14","author":"Maharjan","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jconrel.2026.115157_bb0890","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41746-024-01073-0","article-title":"Digital twins for health: a scoping review","volume":"7","author":"Katsoulakis","year":"2024","journal-title":"NPJ Digit. Med."},{"key":"10.1016\/j.jconrel.2026.115157_bb0895","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41586-025-09442-9","article-title":"The virtual lab of AI agents designs new SARS-CoV-2 nanobodies","volume":"646","author":"Swanson","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115157_bb0900","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50121-3","article-title":"Drug-drug interaction predicting by neural network using integrated similarity","volume":"9","author":"Rohani","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115157_bb0905","doi-asserted-by":"crossref","first-page":"E4304","DOI":"10.1073\/pnas.1803294115","article-title":"Deep learning improves prediction of drug-drug and drug-food interactions","volume":"115","author":"Ryu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115157_bb0910","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s43856-024-00486-y","article-title":"Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning","volume":"4","author":"Wang","year":"2024","journal-title":"Commun. Med. (Lond.)"},{"key":"10.1016\/j.jconrel.2026.115157_bb0915","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s00204-022-03365-4","article-title":"A framework for establishing scientific confidence in new approach methodologies","volume":"96","author":"van der Zalm","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102083","article-title":"mRNA vaccine trafficking and resulting protein expression after intramuscular administration","volume":"35","author":"Hassett","year":"2024","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.jconrel.2026.115157_bb0925","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41578-025-00841-y","article-title":"Inhalable materials and biologics for lung defence and drug delivery","volume":"11","author":"Zhang","year":"2026","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.115157_bb0930","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s42003-023-04555-1","article-title":"Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals","volume":"6","author":"Connors","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0935","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41423-025-01316-4","article-title":"Eliciting antitumor immunity via therapeutic cancer vaccines","volume":"22","author":"Peng","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.115157_bb0940","doi-asserted-by":"crossref","first-page":"21162","DOI":"10.1021\/acsomega.0c02879","article-title":"Head-to-head comparison of the penetration efficiency of lipid-based nanoparticles into tumor spheroids","volume":"5","author":"Niora","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2026.115157_bb0945","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s44385-025-00041-x","article-title":"A 3D spheroid model for assessing nanocarrier-based drug delivery to solid tumors","volume":"2","author":"Yadav","year":"2025","journal-title":"NPJ Biomed. Innov."},{"key":"10.1016\/j.jconrel.2026.115157_bb0950","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40246-023-00502-7","article-title":"New approach methodologies to address population variability and susceptibility","volume":"17","author":"K.T. To","year":"2023","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.jconrel.2026.115157_bb0955","article-title":"Nanoparticles-induced potential toxicity on human health: applications, toxicity mechanisms, and evaluation models","volume":"4","author":"Xuan","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.jconrel.2026.115157_bb0960","article-title":"Organ-on-chip platforms for nanoparticle toxicity and efficacy assessment: advancing beyond traditional in vitro and in vivo models","volume":"33","author":"Sampaio","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115157_bb0965","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/10781552251338047","article-title":"A novel decision tree for performing risk assessments of biologics in a health-system setting","volume":"31","author":"Ngo","year":"2025","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.jconrel.2026.115157_bb0970","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/acs.jcim.5b00294","article-title":"Data quality in the human and environmental health sciences: using statistical confidence scoring to improve QSAR\/QSPR modeling","volume":"55","author":"Steinmetz","year":"2015","journal-title":"J. Chem. Inf. Model."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115157_bb0975","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41587-025-02711-y","article-title":"Lipid nanoparticle screening in nonhuman primates with minimal loss of life","volume":"44","author":"Zenhausern","year":"2026","journal-title":"Nat. Biotechnol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926005602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926005602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:28:19Z","timestamp":1787804899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926005602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":195,"alternative-id":["S0168365926005602"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115157","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New approach methodologies (NAMs) for preclinical and translational evaluation of mRNA\u2013lipid nanoparticle (LNP) therapeutics","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115157"}}